Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of IMPT or IMRT for Breast Cancer: A Prospective Observational Study

NCT06826885 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06826885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06826885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of IMPT or IMRT for Breast Cancer: A Prospective Observational Study
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
November 30, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, efficacy and safety, intensity modulated radiation therapy, proton therapy, radiotherapy, adjuvant